DNA hunt for rare brain disease genes begins
NCT ID NCT06647641
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects DNA from up to 1,000 adults with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA), or related conditions, plus their family members. Researchers will sequence participants' whole genomes to find genetic variants linked to these diseases. The goal is to better understand the genetic roots of these rare neurological disorders.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify new genetic markers linked to these rare brain diseases, paving the way for future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants, and findings may take years to translate into therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORTICOBASAL DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- High-Resolution brain scans aim to unmask Tau's role in Parkinson's
- Can tracking brain changes over time unlock the secrets of frontotemporal dementia?
- Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.
- Can a new rowing seat help veterans with paralysis row freely?
- Wearable sensors aim to catch neurodegenerative decline in real time